Received Jul 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | N/A | BG5J4 | IM / RA |
Vaccine was not appropriate for patient because she received vaccine previously on 12/5/2023 and current recommendations are for 1 dose. Patient has had no adverse reactions to vaccine.